Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
Oncotarget
.
2023 Feb 11:14:129-130.
doi: 10.18632/oncotarget.28346.
Authors
Barbara Marengo
#
1
,
Elda Meta
#
2
3
4
,
Chiara Brullo
2
,
Chiara De Ciucis
1
,
Renata Colla
1
,
Andrea Speciale
5
,
Ombretta Garbarino
1
,
Olga Bruno
#
2
,
Cinzia Domenicotti
#
1
Affiliations
1
Department of Experimental Medicine, General Pathology Section, University of Genoa, Genoa, Italy.
2
Department of Pharmacy, Medicinal Chemistry Section, University of Genoa, Genoa, Italy.
3
Department of Oncology, Laboratory of Angiogenesis and Vascular Metabolism, Katholieke Universiteit Leuven, Leuven, Belgium.
4
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.
5
UOC Mutagenesis and Cancer Prevention, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
#
Contributed equally.
PMID:
36780313
PMCID:
PMC9924827
DOI:
10.18632/oncotarget.28346
No abstract available
Publication types
Published Erratum